Passa al contenuto
Merck
Tutte le immagini(1)

Documenti

MAB5782

Sigma-Aldrich

Anti-NMDAR2B Antibody, NT

ascites fluid, clone 1A8.9B3, Chemicon®

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali


About This Item

Codice UNSPSC:
12352203
eCl@ss:
32160702
NACRES:
NA.41

Origine biologica

mouse

Livello qualitativo

Forma dell’anticorpo

ascites fluid

Clone

1A8.9B3, monoclonal

Reattività contro le specie

human, rabbit, fish, rat, mouse

Produttore/marchio commerciale

Chemicon®

tecniche

western blot: suitable

Isotipo

IgG1

N° accesso NCBI

N° accesso UniProt

Condizioni di spedizione

dry ice

modifica post-traduzionali bersaglio

unmodified

Specificità

NMDAR2B, N-terminal. By Western blot the antibody reacts with bands at ~170 kDa on rat brain lysate. Additional bands at ~116, 50 and 32 kDa may be seen depending on sample and antibody concentration used.

Applicazioni

Detect NMDAR2B using this Anti-NMDAR2B Antibody, N-terminal validated for use in WB.
Western blot: 1:100-1:1,000 on rat brain lysate.

Optimal working dilutions must be determined by end user.

Note legali

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Raccomandato

N° Catalogo
Descrizione
Determinazione del prezzo

Codice della classe di stoccaggio

10 - Combustible liquids

Classe di pericolosità dell'acqua (WGK)

WGK 1

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable


Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Andry Andrianarivelo et al.
Science advances, 7(43), eabg5970-eabg5970 (2021-10-21)
[Figure: see text].
Emilija Glavonic et al.
Pharmaceuticals (Basel, Switzerland), 17(6) (2024-06-27)
Fear-related disorders, including post-traumatic stress disorder (PTSD), and anxiety disorders are pervasive psychiatric conditions marked by persistent fear, stemming from its dysregulated acquisition and extinction. The primary treatment for these disorders, exposure therapy (ET), relies heavily on fear extinction (FE)
D J Laurie et al.
Brain research. Molecular brain research, 51(1-2), 23-32 (1998-01-14)
Mouse monoclonal antibodies were raised against bacterially expressed protein sequences of the NR2A, NR2B, NR2C and NR2D subunits of the rat NMDA receptor. From immunoblots of rat brain proteins, the apparent molecular weights of these subunits were 165, 170, 135
Verónica Guirao et al.
Journal of neurochemistry, 143(3), 359-374 (2017-09-08)
The statin atorvastatin (ATV) given as a post-treatment has been reported beneficial in stroke, although the mechanisms involved are not well understood so far. Here, we investigated in vitro the effect of post-treatment with ATV and its main bioactive metabolite ortho-hydroxy
Núria DeGregorio-Rocasolano et al.
Antioxidants (Basel, Switzerland), 9(12) (2020-12-04)
Death-associated protein kinase 1 (DAPK1) is a pleiotropic hub of a number of networked distributed intracellular processes. Among them, DAPK1 is known to interact with the excitotoxicity driver NMDA receptor (NMDAR), and in sudden pathophysiological conditions of the brain, e.g.

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.